The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes

On Behalf of the MDS/MPN International Working Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The ABNL-MARRO 001 study: a phase 1–2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences